PV legislation and GVP module training

The need for GVP regulatory knowledge

Pharmacovigilance (PV) legislation is built upon the requirement for the continuous monitoring and evaluation of medicinal products to safeguard public health and safety. It comprises a complex framework of laws and regulations, guidelines, and mandates, with a mixture of harmonised global or regional standards, such as European Medicine Agency’s (EMA) Good Pharmacovigilance Practices (GVP), supplemented at the national level with local requirements and differences.




Understanding and adhering to these guidelines is therefore a legal requirement for pharmaceutical companies marketing products, and failure to do so can result in fines, product removal, reputational damage and more, so it is essential that PV personnel are fully trained on what is required, and ready for audits and inspections.

Why iVigee is your best GVP training partner.

iVigee’s GVP training experts have years of direct pharmacovigilance experience with GVP and we are recognised as leaders in this area by organisations such as the Drug Information Association (DIA), where our leadership team are a part of their own GVP training programmes.

We understand that each organization has unique needs, and we offer tailor-made training solutions designed to address that alongside your specific challenges and objectives for a more effective and relevant learning experience. And our range of flexible training options are also designed to suit different learning preferences, including face-to-face sessions, eLearning platforms, and self-study materials, ensuring accessibility for all participants.

Our training not only covers PV legislation and GVP requirements from a global perspective, but we can also introduce insights into regional differences and international standards, making it suitable for organisations operating in multiple jurisdictions. Through our world leading Regulatory Intelligence platform iViReg, we can ensure that all training on local requirements is based on the very latest information available in over 90 countries.

All training participants receive certification upon completion, contributing to their professional development and demonstrating their commitment to maintaining high standards of pharmacovigilance practice.